MCL1 and neoplasm: Our data suggest that several growth factors produced by tumor-associated stromal cells within the developing metastatic niche drive ERK activity and increased MCL1 expression in subsets of osteosarcoma cells, and that both ERK activity and MCL1 expression are particularly elevated in early metastases.